Concert Pharmaceuticals, Inc. (CNCE): Price and Financial Metrics
CNCE Price/Volume Stats
| Current price | $8.37 | 52-week high | $8.55 |
| Prev. close | $8.36 | 52-week low | $2.66 |
| Day low | $8.35 | Volume | 10,733,200 |
| Day high | $8.55 | Avg. volume | 2,970,800 |
| 50-day MA | $7.49 | Dividend yield | N/A |
| 200-day MA | $5.99 | Market Cap | 401.24M |
CNCE Stock Price Chart Interactive Chart >
Concert Pharmaceuticals, Inc. (CNCE) Company Bio
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform (deuterated chemical entity platform) to create novel small molecule drugs. The company was founded in 2006 and is based in Lexington, Massachusetts.
CNCE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 119.11% |
| 5-year | 20.26% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 85.40% |
| 2021 | -75.08% |
| 2020 | 37.02% |
| 2019 | -26.49% |
Continue Researching CNCE
Want to do more research on Concert Pharmaceuticals Inc's stock and its price? Try the links below:Concert Pharmaceuticals Inc (CNCE) Stock Price | Nasdaq
Concert Pharmaceuticals Inc (CNCE) Stock Quote, History and News - Yahoo Finance
Concert Pharmaceuticals Inc (CNCE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...